Open Access
Med Buccale Chir Buccale
Volume 18, Number 4, novembre 2012
Page(s) 325 - 331
Section Articles originaux / Original articles
Published online 28 September 2012
  1. D’Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck 2004;26:232–40. [CrossRef] [PubMed] [Google Scholar]
  2. Sharwani A, Jerjes W, Hopper C, Lewis MP, El-Maaytah M, Khalil HS, Macrobert AJ, Upile T, Salih V. Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer. Arch Oral Biol 2006;51:1104–11. [CrossRef] [PubMed] [Google Scholar]
  3. Tan IB, Oppelaar H, Ruevekamp MC, Veenhuizen RB, Timmers A, Stewart FA. The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors. Head Neck 1999;21:434–41. [CrossRef] [PubMed] [Google Scholar]
  4. Kramer S, Marcial VA, Pajak TF, MacLean CJ, Davis LW. Prognostic factors for loco/regional control and metastasis and the impact on survival. Int J Radiat Oncol Biol Phys 1986;12:573–8. [CrossRef] [PubMed] [Google Scholar]
  5. Wheeler RH. Chemotherapy of patients with recurrent head and neck cancer (pp. 171-93). In: Jacobs C, Ed. Carcinomas of the head and neck: evaluation and management. Kluewer Academic Publishers, Boston, 1990. [Google Scholar]
  6. Fan KF, Hopper C, Speight PM, Buonaccorsi GA, Brown SG. Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int J Cancer 1997;73:25–32. [CrossRef] [PubMed] [Google Scholar]
  7. Grosjean P, Savary JF, Mizeret J, Wagnieres G, Woodtli A, Theumann JF, Fontolliet C, Van den Bergh H, Monnier P. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra (m-hydroxyphenyl) chlorine. J Clin Laser Med Surg 1996;14:281–7. [PubMed] [Google Scholar]
  8. Kübler AC, de Carpentier J, Hopper C, Leonard AG, Putnam G. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy. Int J Oral Maxillofac Surg 2001;30:504–9. [CrossRef] [PubMed] [Google Scholar]
  9. Marchal S, Francois A, Dumas D, Guillemin F, Bezdetnaya L. Relationship between subcellular localisation of Foscan® and caspase activation in photosensitised MCF-7 cells. Br J Cancer 2004;96:944–51. [CrossRef] [Google Scholar]
  10. Henderson B, Dougherty T. How does photodynamic therapy work? Photochem Photobiol 1992;55:145–57. [CrossRef] [PubMed] [Google Scholar]
  11. Kübler A, Haase T, Staff C, Kahle U, Mühling J. Photodynamic therapy of primary non-melanomatous skin tumours of the head and neck. Laser Surg Med 1999;25:60–8. [CrossRef] [Google Scholar]
  12. Peng Q, Warloe T, Berg K, Moan J, Kongshauq M, Giercksky KE, Nesland JM. 5-aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997;79:2282–308. [Google Scholar]
  13. Yang TH, Chen CT, Wang CP, Lou PJ. Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro. Oral Oncol 2007;43:358–65. [CrossRef] [PubMed] [Google Scholar]
  14. Lou PJ, Jager HR, Jones L, Theodossy T, Brown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 2004;91:441–6. [CrossRef] [PubMed] [Google Scholar]
  15. Hermanek P, Sobin LH, Ed. International Union Against Cancer (UICC). TNM classification of malignant tumours, 4th ed. Springer-Verlag, Berlin, 1987 [revised 1992]. [Google Scholar]
  16. Copper MP, Triesscheijn M, Tan IB, Ruevekamp MC, Stewart FA. Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx. Clin Otolaryngol 2007;32:185–9. [CrossRef] [PubMed] [Google Scholar]
  17. Dolivet G, Gangloff P, Sarini J, Ton Van J, Garron X, Guillemin F, Lefebvre JL. Modification of the infra hyoid musculo-cutaneous flap. Eur J Surg Oncol 2005;31:294–8. [CrossRef] [PubMed] [Google Scholar]
  18. Gangloff P, Deganello A, Lacave ML, Verhaeghe JL, Lapeyre M, Maire F, Phulpin B, Guillemin F, Dolivet G. Use of the infra hyoid musculo-cutaneous flap in soft palate reconstruction. Eur J Surg Oncol 2006;32:1165–9. [CrossRef] [PubMed] [Google Scholar]
  19. Allison RR, Cuence RE, Downie GH, Camnitz P, Brodish B, Sibata CH. Clinical photodynamic therapy of head and neck cancers – A review of applications and outcomes. Photodiagnosis Photodyn Ther 2005;2:205–22. [CrossRef] [PubMed] [Google Scholar]
  20. MacCormack MA. Photodynamic therapy. Adv Dermatol 2006;22:219-58. [CrossRef] [PubMed] [Google Scholar]
  21. Kübler AC. Photodynamic therapy. Med Laser Application 2005;20:37–45. [CrossRef] [Google Scholar]
  22. Hopper C, Kubler A, Lewis H, Tan IB, Putnam G. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 2004;111:138–46. [CrossRef] [PubMed] [Google Scholar]
  23. Hopper C, Niziol C, Sidhu M. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncol 2004;40:372–82. [CrossRef] [PubMed] [Google Scholar]
  24. Tan IB, Dolivet G, Ceruse P, Van der Poorten V, Roest G, Rauschning W. Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study. Head Neck 2010;32:1597–604. [CrossRef] [PubMed] [Google Scholar]
  25. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 2000;1:212–9. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.